Managing anemia in patients with chronic heart failure: what do we know?

作者: Anatole Besarab

DOI: 10.2147/VHRM.S4619

关键词:

摘要: Anemia is common in patients with chronic heart failure (HF) an incidence ranging from 4% to 55% depending on the studied population. Several studies have highlighted that prevalence of anemia increases worsening as reflected by New York Heart Association classification. Additionally, several epidemiological its role a prognostic marker, linking it worse outcomes including; malnutrition, increased hospitalizations, refractory and death. The pathophysiology multifactorial related various factors hemodilution, iron losses anti-platelet drugs, activation inflammatory cascade, urinary erythropoietin associated renal insufficiency. There are host examining HF anemia, but only few randomized trials addressing this issue. purpose article review literature examines interrelationship congestive HF, analyzing etiology, impact also kidney disease well cardiorenal syndrome both marker morbidity mortality.

参考文章(100)
HW Radtke, A Claussner, PM Erbes, EH Scheuermann, W Schoeppe, KM Koch, Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function. Blood. ,vol. 54, pp. 877- 884 ,(1979) , 10.1182/BLOOD.V54.4.877.877
Tiziana Bachetti, Angelo Corti, Amerigo Giordano, Roberto Ferrari, None, Tumor Necrosis Factor-Alpha in Chronic Heart Failure Springer, Boston, MA. pp. 3- 8 ,(1995) , 10.1007/978-1-4615-2003-0_1
Dariush Mozaffarian, Regina Nye, Wayne C Levy, Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE). Journal of the American College of Cardiology. ,vol. 41, pp. 1933- 1939 ,(2003) , 10.1016/S0735-1097(03)00425-X
Hessel F. Groenveld, James L. Januzzi, Kevin Damman, Jan van Wijngaarden, Hans L. Hillege, Dirk J. van Veldhuisen, Peter van der Meer, Anemia and Mortality in Heart Failure Patients: A Systematic Review and Meta-Analysis Journal of the American College of Cardiology. ,vol. 52, pp. 818- 827 ,(2008) , 10.1016/J.JACC.2008.04.061
Paul C Hébert, George Wells, Morris A Blajchman, John Marshall, Claudio Martin, Giuseppe Pagliarello, Martin Tweeddale, Irwin Schweitzer, Elizabeth Yetisir, Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group, A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care The New England Journal of Medicine. ,vol. 340, pp. 409- 417 ,(1999) , 10.1056/NEJM199902113400601
David Sheps, Dov Wexler, Adrian Iaina, Miriam Blum, Donald S Silverberg, Gad Keren, Doron Schwartz, Effect of correction of anemia with erythropoietin and intravenous iron in resistant heart failure in octogenarians. Israel Medical Association Journal. ,vol. 5, pp. 337- 339 ,(2003)
Inder S. Anand, Anemia and Chronic Heart Failure: Implications and Treatment Options Journal of the American College of Cardiology. ,vol. 52, pp. 501- 511 ,(2008) , 10.1016/J.JACC.2008.04.044
Dov Wexler, Adrian Iaina, Donald S Silverberg, The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron Journal of Nephrology. ,vol. 17, pp. 749- 761 ,(2004)